Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.9%

1 terminated out of 53 trials

Success Rate

96.9%

+10.4% vs benchmark

Late-Stage Pipeline

17%

9 trials in Phase 3/4

Results Transparency

10%

3 of 31 completed with results

Key Signals

3 with results97% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (10)
P 1 (9)
P 2 (6)
P 3 (1)
P 4 (8)

Trial Status

Completed31
Unknown9
Recruiting6
Not Yet Recruiting3
Terminated1
Active Not Recruiting1

Trial Success Rate

96.9%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07541807CompletedPrimary

Assessing Changes in Gadoxetate Metabolism by the Liver Using MRI

NCT06916078Phase 1RecruitingPrimary

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

NCT04618692Not ApplicableCompleted

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

NCT03193151RecruitingPrimary

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

NCT06486805Phase 4Completed

N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement

NCT07144501Not ApplicableNot Yet Recruiting

Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.

NCT06950398Phase 2Not Yet Recruiting

Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers

NCT06173947Recruiting

SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury

NCT05082077Enrolling By Invitation

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

NCT06178302Not Yet RecruitingPrimary

DEscripitive Patient Analysis to Enable Risk-based Quality Improvement Measures in a lArge iNternal mediCIne grouP Practice

NCT06793007CompletedPrimary

Variants Of Intrahepatic Biliary Radicals in Nepali Population

NCT06126419Not ApplicableRecruitingPrimary

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

NCT05817994Withdrawn

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

NCT03519074Phase 2Active Not Recruiting

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

NCT06532214Recruiting

Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy

NCT06403553CompletedPrimary

FC Change From Day 1 to Day 3 Associated With SALD

NCT06220929Phase 4Unknown

Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury

NCT05999331UnknownPrimary

Elevated Initial APRI Value Was Associated With SALD

NCT03833297Completed

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

NCT05793203Recruiting

Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients

Scroll to load more

Research Network

Activity Timeline